Baogeng Hou

发表

Discovery of benzamide-based PI3K/HDAC dual inhibitors with marked pro-apoptosis activity in lymphoma cells.

Xiaohan Hou, Xiaoyang Li, Jingjing Deng, 2023, European journal of medicinal chemistry.